Meclizine Hydrochloride
NDC 50436-3988
Product Information
Meclizine Hydrochloride is a ANDA-approved product labeled by Unit Dose Services. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a yellow product. This product entry covers the primary NDC 50436-3988 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
PAR;035
Code Structure Chart
Product Details
What is NDC 50436-3988?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- MECLIZINE HYDROCHLORIDE (UNII: HDP7W44CIO)
- MECLIZINE (UNII: 3L5TQ84570) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ANHYDROUS LACTOSE (UNII: 3SY5LH9PMK)
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)
- STARCH, CORN (UNII: O8232NY3SJ)
- STEARIC ACID (UNII: 4ELV7Z65AP)
- WATER (UNII: 059QF0KO0R)
- ISOPROPYL ALCOHOL (UNII: ND2M416302)
- D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- FD&C YELLOW NO. 5 (UNII: I753WB2F1M)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 995666 - meclizine HCl 25 MG Oral Tablet
- RxCUI: 995666 - meclizine hydrochloride 25 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.
Patient Education
Meclizine
Meclizine is used to prevent and treat nausea, vomiting, and dizziness caused by motion sickness. It is most effective if taken before symptoms appear.
[Learn More]
* Please review the full disclaimer at the bottom of this page.